Yuhan Corporation Signs Technology Export Deal Worth 480 Billion KRW for Gastrointestinal Treatment with U.S. Pharmaceutical Company
[Asia Economy Reporter Park Jihwan] Yuhan Corporation announced on the 20th that it has decided to license out its functional gastrointestinal treatment new drug 'YH12852' to the U.S. pharmaceutical company Processa Pharmaceuticals for a total of $410.5 million (approximately 483.6 billion KRW).
Hot Picks Today
!["Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/93/2025061015355092669_1749537351.jpg)
"Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Michelin 2-Star Restaurant Owner Faces Trial Over "Ant Topping Dessert"
- "Drink Three Cups of Coffee and Stay Up All Night Before the Test"... Manual of Insurance Planner Who Collected 1 Billion Won in Payouts
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
